Search clinical trials for: MP4CO

Total 2 results

  • Sangart
    Withdrawn
    Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
    Sickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C Disease
    France, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
  • Sangart
    Completed
    Safety Study of MP4CO in Adult Sickle Cell Patients
    Sickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C Disease
    United Kingdom, France, Jamaica, Lebanon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe